查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861978

骨水泥和骨黏合劑市場按產品類型、應用、最終用戶、技術和分銷管道分類－2025-2032年全球預測

Bone Cement & Glue Market by Product Type, Application, End User, Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，骨水泥和黏合劑市場將成長至 32.9 億美元，複合年成長率為 6.56%。

關鍵市場統計數據
基準年 2024 19.8億美元
預計年份：2025年 21.1億美元
預測年份 2032 32.9億美元
複合年成長率 (%) 6.56%

清楚地介紹了生物材料創新和不斷發展的臨床工作流程如何重新定義骨水泥和外科黏合劑的選擇。

隨著生物材料技術的進步與外科手術流程的不斷演進，骨水泥和黏合劑領域正吸引臨床、監管和商業相關人員的廣泛關注。本報告首先對骨水泥和黏合劑在現代整形外科、顱顏外科、牙科和脊椎外科治療路徑中的地位進行概述，並闡明其成分、劑型和最終用戶環境的差異如何影響其應用和臨床療效。

臨床團隊越來越傾向於選擇兼具操作性能和生物活性的材料。因此，該領域的產品組合正從傳統的聚甲基丙烯酸甲酯（PMMA）基水泥擴展到旨在促進組織整合或局部給藥的新型生物活性材料。同時，隨著集團採購組織、競標主導的醫院合約以及與優先考慮長期價值和供應穩定性的製造商直接交易的興起，分銷和採購模式也在進行重組。

從採購方的觀點來看，技術選擇受手術複雜程度、設施容量和報銷趨勢的影響，導致醫院手術室、門診手術中心和專科診所的採用率存在差異。因此，相關人員不僅要根據關鍵績效指標評估產品系列，還要考慮滅菌、儲存以及與術中工作流程的兼容性。本導言概述了這些趨勢，並為後續的詳細分析奠定了基礎。

生物材料的進步、手術流程向門診轉移以及監管要求的提高將如何重塑市場動態和臨床應用？

過去幾年，材料科學的突破、外科手術技術的革新以及監管力度的加大，徹底改變了骨水泥和外科黏合劑的競爭格局和臨床應用現狀。生物活性配方的創新已從概念驗證發展到常規臨床評估階段，使得促進骨整合和實現可控吸收特性的材料成為可能。同時，注射型和可塑型等給藥方式的改進，也擴大了這些產品在微創和門診手術的應用範圍。

同時，成本控制壓力和縮短住院時間的趨勢導致某些手術逐漸從住院機構轉移到門診手術中心和專科診所。這種轉變迫使供應商改善包裝、滅菌和操作特性，以適應低風險環境，因為這些場所的空間和設備與傳統的手術室環境不同。手術施行地點的轉移也凸顯了產品易用性和在有限時限內可預測的性能的重要性。

監管要求也在不斷提高，特別是對含抗菌藥物產品的安全性標籤要求以及支持長期治療效果的臨床數據。因此，各公司正大幅增加對臨床證據產生和上市後監測的投入。材料創新、不斷變化的治療環境以及監管的加強，共同提高了市場准入和持續商業性成功的門檻，同時也為企業開闢了新的差異化競爭途徑。

評估近期關稅如何促使各產業進行策略性供應鏈重組、採購區域化和商業合約轉型。

2025年關稅的實施和貿易政策的變化，標誌著骨水泥和骨接合劑產業的供應鏈策略迎來了一個明顯的轉折點。中間投入品和成品的進口關稅增加了依賴跨境生產聚合物、活性添加劑和包裝材料的製造商的到岸成本。為此，各公司正在重新評估籌資策略，同時加快生產能力的區域化，以降低關稅波動帶來的風險，並確保向關鍵臨床客戶按時交付產品。

隨著原物料成本上漲，採購部門越來越重視以價值基本契約和長期供應協議，以鎖定價格和服務水準。這促使他們與經銷商和集團採購組織進行更多談判，而這些組織本身也在調整供應商組合，優先選擇擁有穩定近岸生產基地的製造商。因此，那些製造地不多元化或依賴單一供應商的公司，要么被迫尋找替代供應商，要么投資建立本地生產能力。

關稅環境也在推動包裝和產品設計方面的創新，以最佳化運輸效率並降低基於重量和體積的關稅。同時，企業正在加快與區域合作夥伴進行契約製造和授權合作，以規避某些貿易壁壘，同時保持市場連續性。這些戰略應對措施並非簡單的戰術性成本削減措施，而是影響競爭地位、新配方上市時間以及供應鏈在不斷變化的貿易政策下韌性的長期決策。

詳細的細分分析揭示了產品化學成分、臨床應用、終端用戶環境、技術類型和分銷選擇如何驅動不同的採用路徑。

細分市場分析揭示了產品化學成分、臨床應用、終端用戶環境、技術等級和分銷模式等方面的細微性能特徵和應用路徑差異。按產品類型分類，市場由丙烯酸骨水泥和磷酸鈣骨水泥組成。丙烯酸骨水泥又可分為含抗生素配方（用於滿足感染控制通訊協定）和不含抗生素配方（用於滿足標準固定需求）。同時，磷酸鈣骨水泥則提供注射型和可塑性兩種形式，以滿足微創給藥和術中塑形需求。

從應用角度來看，臨床需求分佈在顱顎顏面外科、口腔科和整形外科等多個專科。顱顎顏面的適應症主要集中在重組手術和創傷修復，尤其注重輪廓恢復和固定。口腔科的應用涵蓋植入和修復手術，其中生物相容性和可操作性會影響骨整合。整形外科的應用包括骨折固定、關節重建和脊椎手術，每種手術都有其獨特的機械和生物性能要求，這些要求會影響材料的選擇。

終端用戶的需求差異顯著。包括多專科中心和整形外科中心在內的門診手術中心，優先考慮快速治療、易於操作以及能夠提升處理效率的價值體系。同時，公立和私立醫院則需要能夠應對複雜手術且符合機構採購通訊協定的多功能性。包括牙科診所和門診復健中心在內的專科診所，則需要小包裝和易於使用的配送系統，以滿足高頻次的門診工作流程。

技術細分區分了生物活性方法和基於PMMA的平台。生物活性技術包括磷酸鈣和矽酸鈣等，旨在與活體組織相互作用並促進癒合。另一方面，基於PMMA的解決方案提供高黏度和低黏度兩種選擇，這些黏度因其機械穩定性和操作性能而被選中。從分銷角度來看，透過OEM合作關係或競標合約進行直接銷售非常適合大型機構客戶。同時，經銷商透過集團採購組織或獨立管道觸達更廣泛的基本客群，而由電子商務平台和製造商網站組成的線上管道對於小批量採購者和需要快速補貨的客戶而言正變得越來越重要。這些細分維度共同構成了一個需求訊號矩陣，製造商和供應商必須解讀這些訊號，才能有效調整其產品開發、行銷和銷售策略。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢將影響招聘趨勢、監管重點和供應策略。

區域趨勢對商業化策略和產品開發重點均有顯著影響。在美洲，成熟的醫院基礎設施、廣泛的私立醫院網路以及不斷擴展的門診手術能力正在塑造市場需求趨勢，這些因素共同為成熟的PMMA基產品以及新興的、用於控制感染和促進骨整合的生物活性配方創造了機會。該地區成熟的採購模式正在推動建立長期的供應商關係和結構化的合約機制，這些機制重視基於實證的績效和可靠的供應鏈。

在歐洲、中東和非洲地區，監管協調和多樣化的醫療模式造就了錯綜複雜的市場接受度曲線。西歐市場需要嚴謹的臨床數據，並且通常是先進生物活性材料應用的中心；而該地區的其他市場則可能更注重成本效益和供應鏈的適應性。新興市場在基礎設施投資和外科手術服務覆蓋範圍擴大的推動下，展現出巨大的成長潛力，但同時也需要客製化的分銷策略和靈活的定價結構。

亞太地區的市場成熟度差異顯著，大型都市區醫療中心採用先進的材料和輸送系統，而農村地區則更注重價格實惠和使用便利。多個國家的在地化生產基地和充滿活力的醫療技術創新生態系統正在加速產品在地化和客製化進程。在整個亞太地區，供應鏈韌性、監管完整性以及展現臨床和經濟價值的能力仍然是產品持續應用和市場滲透的關鍵因素。

競爭格局概述，展示了現有企業、專業創新者和通路合作夥伴如何塑造產品差異化和市場進入策略。

骨水泥和外科黏合劑領域的競爭動態由成熟製造商、特種生醫材料公司、契約製造以及專注於下一代生物活性化學物質的創新Start-Ups共同構成。成熟企業受益於與大型醫院系統的牢固關係、廣泛的商業性佈局以及在多個司法管轄區獲得監管核准的經驗。這些企業利用規模經濟最佳化生產成本，投資於臨床證據開發，並經常提供包含儀器和培訓在內的捆綁式解決方案。

同時，中型和新興企業正透過專注於利基技術來實現差異化競爭，例如具有複雜洗脫特性的抗生素浸漬骨水泥、專為特定整形外科領域設計的磷酸鈣基產品，以及能夠減少術中變異性的精準輸送平台。契約製造組織（CMO）正發揮日益重要的策略作用，它們幫助規模較小的創新企業管理品管系統和法規遵從性，同時擴大生產規模。

經銷合作夥伴，包括全國性經銷商和集團採購組織，是醫院處方箋集和門診網路的安全隔離網閘。他們對採購決策的影響凸顯了通路策略的重要性，該策略需要平衡直接銷售關係和廣泛的分銷協議。隨著產品上市速度和遵守當地法規成為優先事項，夥伴關係和授權模式也變得十分普遍。整體而言，競爭優勢取決於公司展現臨床差異化、維持供應連續性以及與採購、臨床試驗點和醫院經營團隊等相關人員保持良好關係的能力。

在不斷變化的醫療保健環境中，製造商和供應商應採取切實可行的策略重點，以增強臨床差異化、供應鏈韌性和商業性擴充性。

骨水泥和骨接合劑領域的領導企業應採取多管齊下的策略，兼顧產品卓越性、供應鏈韌性以及與不斷發展的臨床路徑的契合。首先，他們應投資於臨床證據項目，這些項目不僅要滿足監管要求，還要產生真實世界的結果數據，以證明感染率降低、植入穩定性提高以及患者康復時間縮短。這些數據有助於在採購談判中形成差異化的價值提案，並推動產品進入醫院處方集和優選供應商名單。

其次，我們正在實現製造地和採購基礎多元化，以降低貿易政策風險，並確保對關鍵醫院客戶的持續供應。這包括發展區域製造夥伴關係、委託製造協議，以及選擇性地進行近岸外包，以縮短前置作業時間和降低關稅風險。同時，我們也在最佳化包裝和物流，以最大限度地降低運輸成本，並滿足門診環境的特殊需求，因為門診的空間和設備與傳統手術室有所不同。

第三，最佳化您的商業模式，平衡直銷、經銷商夥伴關係和數位化通路。雖然與大型機構買家直接合作對於複雜的產品仍然至關重要，但經銷商和線上平台可以幫助您拓展客戶群體，涵蓋規模較小的診所和牙科診療機構。此外，優先考慮能夠簡化產品操作並展示流程效率的培訓和教育項目。臨床醫師重視能夠減少術中不確定性的實務支持和實證通訊協定。

最後，我們將推動以使用者為中心的產品功能研發，例如可調節的設定時間、更高的滲透性和相容的輸送工具。產品開發將與策略聯盟結合，以加速臨床檢驗和監管核准。這些措施的全面實施將鞏固我們的市場地位，並在臨床和採購環境不斷變化的情況下，打造永續的競爭優勢。

結合臨床醫生訪談、供應商文件分析和多方面資料檢驗的穩健混合調查方法確保了研究的實用性和嚴謹性。

本分析所依據的研究融合了定性和定量方法，以確保獲得全面且基於證據的見解。主要研究包括對整形外科、顱顏外科和牙科臨床醫生、醫院和門診手術中心的採購主管、生物材料製造商的產品經理以及分銷主管進行結構化訪談。這些訪談直接揭示了影響產品選擇的臨床性能預期、採購決策促進因素和營運限制。

二次研究包括對同行評審文獻、監管指導文件和已發表的臨床研究摘要系統性回顧，以檢驗材料特性、性能聲明和安全性概況。此外，還分析了供應商文件、產品說明書和臨床技術指南，以評估操作特性和使用通訊協定。資料三角驗證法整合了來自一手訪談和二級資訊來源的發現，以識別共同的主題並調和相互衝突的觀點。

分析方法包括對定性訪談記錄進行主題編碼、跨產品類型和技術進行比較特徵映射，以及情境分析以評估供應鏈中斷和政策變化的影響。品質保證流程包括與多位受訪者進行交叉檢驗、由領域專家對研究結果草稿進行同行評審，以及遵守資料來源和方法論假設的透明文件標準。這種嚴謹的方法論為相關人員提供了既具有實務意義又具有分析嚴謹性的研究結果，可供其在策略和營運規劃中使用。

策略概述重點在於臨床表現、採購重點和供應鏈韌性的整合，以定義未來的市場領導

總而言之，骨水泥和外科黏合劑市場正朝著兼具可靠機械性能、生物活性和在各種手術環境中易於操作的解決方案轉型。這項轉變的驅動力來自臨床對改善治療效果的需求、強調價值和供應穩定性的採購壓力，以及優先考慮病人安全和實證實踐的監管要求。將產品開發與臨床工作流程結合，並投資於擴充性、在地化且具彈性的供應模式的相關人員，將更有利於把握新的機會。

隨著產業發展，成功將越來越取決於能否將材料科學轉化為可操作的臨床效益（例如降低感染風險、改善固定效果、加速病患復原），同時也要應對分銷和採購方面的複雜性。在設計階段早期就讓臨床醫生參與其中，與區域製造商和契約製造製造商合作以確保供應，並採用數據驅動的價值提案，這種協作方式將使供應商在競爭激烈的市場中脫穎而出。總而言之，那些將成熟的臨床價值與卓越的營運和策略靈活性相結合的公司前景光明。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於關節重建手術感染預防的含抗生素PMMA骨水泥配方迅速增加
  • 開發一種完全可生物分解的磷酸鈣骨接合劑，能夠實現骨骼隨時間推移的完全再生。
  • 將幹細胞載體整合到生物活性骨黏附基質中，以促進術後局部組織癒合
  • 採用結合光固化和化學固化的雙重固化牙科黏合劑，提高了黏合耐久性。
  • 擴大獸用骨水泥在伴侶動物骨折修復手術的應用範圍
  • 在整形外科手術中，利用3D列印技術製作患者特異性骨水泥模具，用於複雜的植入幾何形狀。
  • 透過聚合物化學家和骨科醫生的合作，開發出一種熱敏性可注射骨接合劑

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的骨水泥和骨黏合劑市場

  • 丙烯酸骨水泥
    • 含有抗生素
    • 不含抗生素
  • 磷酸鈣水泥
    • 射出模具
    • 可塑性型

9. 按應用分類的骨水泥和骨黏合劑市場

  • 顱顎顏面外科
    • 重組手術
    • 創傷修復
  • 牙科
    • 植入
    • 維修
  • 整形外科
    • 骨折固定
    • 關節重建
    • 脊椎手術

第10章 依最終用戶分類的骨水泥和骨黏合劑市場

  • 門診手術中心
    • 多專科醫療機構
    • 整形外科中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所
    • 牙醫診所
    • 門診復健

第11章 依技術分類的骨水泥和骨黏合劑市場

  • 生物活性
    • 磷酸鈣
    • 矽酸鈣
  • PMMA基材
    • 高黏度
    • 低黏度

第12章 骨水泥和骨黏合劑市場（依通路分類）

  • 直銷
    • 原廠設備製造商
    • 競標合約
  • 經銷商
    • 集團採購組織
    • 獨立經銷商
  • 線上管道
    • 電子商務平台
    • 製造商官方網站

第13章 骨水泥和骨黏合劑市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 骨水泥和骨黏合劑市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國骨水泥和骨黏合劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • DePuy Synthes, Inc.
    • Heraeus Medical GmbH
    • Smith & Nephew plc
    • B. Braun Melsungen AG
    • Medtronic plc
    • TEI Biosciences, Inc.
    • DJO Global, Inc.
    • Paragon 28, LLC
Product Code: MRR-521BAA36EADE

The Bone Cement & Glue Market is projected to grow by USD 3.29 billion at a CAGR of 6.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.98 billion
Estimated Year [2025] USD 2.11 billion
Forecast Year [2032] USD 3.29 billion
CAGR (%) 6.56%

A clarifying introduction to how biomaterial innovation and clinical workflow evolution are redefining bone cement and surgical adhesive selection

The bone cement and adhesive landscape is experiencing heightened attention from clinical, regulatory, and commercial stakeholders as advances in biomaterials converge with evolving surgical workflows. This report opens with an oriented introduction that situates bone cement and glue within contemporary orthopedic, craniofacial, dental, and spinal care pathways, clarifying how variations in composition, delivery formats, and end-user settings influence adoption and clinical outcomes.

Clinical teams increasingly demand materials that balance handling characteristics with biological performance. Consequently, the sector's product mix now spans traditional polymethyl methacrylate (PMMA)-based cements and newer bioactive chemistries designed to support tissue integration or deliver localized therapeutics. Meanwhile, distribution and procurement models are being reshaped by the rise of group purchasing organizations, tender-driven hospital contracts, and direct manufacturer relationships that prioritize long-term value and supply resilience.

From a buyer's perspective, technology selection is influenced by procedural complexity, setting capabilities, and reimbursement dynamics, leading to differentiated uptake across hospital operating rooms, ambulatory surgical centers, and specialty clinics. As a result, stakeholders must evaluate product portfolios not only on primary performance metrics but also on sterilization, storage, and in-procedure workflow compatibility. This introduction frames those dynamics and sets expectations for the deeper analysis to follow.

How advances in biomaterials, procedural migration to outpatient settings, and elevated regulatory requirements are reshaping market dynamics and clinical adoption

Over the past several years, transformative shifts have altered both the competitive and clinical landscapes for bone cements and surgical glues, driven by material science breakthroughs, procedural migration, and heightened regulatory scrutiny. Innovations in bioactive formulations have advanced from proof-of-concept to routine clinical evaluation, enabling materials that promote osteointegration and provide controlled resorption profiles. At the same time, improvements in delivery mechanisms, such as injectable and moldable formats, have expanded the range of minimally invasive and outpatient procedures that can reliably utilize these products.

Concurrently, there has been a steady movement of select procedures from inpatient settings to ambulatory surgical centers and specialty clinics, prompted by cost containment pressures and the drive to reduce hospital length of stay. This migration has pushed suppliers to refine packaging, sterilization, and handling features to suit lower-acuity settings where space and instrumentation differ from traditional OR environments. Transitioning procedural venues has also highlighted the importance of product ease-of-use and predictable performance under constrained time windows.

Regulatory expectations have intensified, particularly around safety labeling for antibiotic-loaded products and clinical data supporting long-term outcomes. As a result, companies are investing more heavily in clinical evidence generation and post-market surveillance. These combined shifts - material innovation, procedural migration, and regulatory focus - are creating new avenues for competitive differentiation while raising the bar for market entry and sustained commercial success.

Assessing how recent tariff measures have prompted strategic supply chain reconfiguration, sourcing regionalization, and commercial contracting shifts across the sector

The introduction of tariffs and trade policy changes in 2025 has created a measurable inflection point for supply chain strategies across the bone cement and glue sector. Import duties on intermediate inputs and finished devices have increased landed costs for manufacturers that rely on cross-border production of polymers, active additives, and packaging materials. In response, firms are reassessing sourcing strategies while accelerating regionalization of manufacturing capacity to reduce exposure to tariff volatility and to safeguard delivery timelines to key clinical customers.

As procurement teams adapt to higher input costs, there is stronger emphasis on value-based contracting and longer-term supply agreements that lock in pricing and service levels. This has intensified negotiations with distributors and group purchasing organizations, which are themselves recalibrating supplier portfolios to prioritize manufacturers with secure, near-shore production footprints. Consequently, companies without diversified manufacturing nodes or those dependent on single-source suppliers are under pressure to either secure alternative suppliers or to invest in localized production capabilities.

The tariff environment has also catalyzed innovation in packaging and product design to optimize transport efficiency and reduce weight- or volume-based duties. In parallel, firms are increasingly exploring toll manufacturing and licensing arrangements with regional partners to maintain market continuity while bypassing certain trade barriers. These strategic responses are not only tactical cost mitigations but also long-term decisions that influence competitive positioning, time-to-market for new formulations, and the resilience of supply chains amid shifting trade policies.

In-depth segmentation analysis reveals how product chemistry, clinical application, end-user settings, technology types, and distribution choices drive differentiated adoption pathways

Segmentation analysis reveals nuanced performance characteristics and adoption pathways that vary by product chemistry, clinical application, end-user setting, technology class, and distribution model. In terms of product type, the market encompasses acrylic bone cement and calcium phosphate cement; the acrylic segment is distinguished by antibiotic-loaded formulations and non-antibiotic variants that cater to infection control protocols and standard fixation needs respectively, while calcium phosphate alternatives are offered in injectable and moldable forms that respond to preferences for minimally invasive delivery or intraoperative shaping.

When viewed through the lens of application, clinical demand is distributed across craniomaxillofacial, dental, and orthopedic specialties. Craniomaxillofacial indications focus on reconstructive surgery and trauma repair with an emphasis on contour restoration and fixation; dental applications span implantology and restorative procedures where biocompatibility and handling impact osseointegration; orthopedic uses cover fracture fixation, joint replacement, and spinal surgery, each with distinct mechanical and biological performance imperatives that inform material selection.

End-user differentiation is significant: ambulatory surgical centers-comprising multi-specialty and orthopedic centers-prioritize quick-setting, easy-to-handle systems that align with accelerated throughput, whereas hospitals, both private and public institutions, demand versatility across complex procedures and compatibility with institutional purchasing protocols. Specialty clinics, including dental clinics and outpatient rehabilitation centers, require smaller package formats and user-friendly delivery systems tailored to high-volume, outpatient workflows.

Technology segmentation separates bioactive approaches from PMMA-based platforms. Bioactive technologies include calcium phosphate and calcium silicate variants designed to interact with host tissue and promote healing, while PMMA-based solutions present high-viscosity and low-viscosity options chosen for their mechanical stability and handling characteristics. From a distribution perspective, direct sales arrangements-built on OEM relationships and tender contracts-favor large institutional customers, distributors operate through group purchasing organizations and independent channels to reach a broader base, and online channels, comprising e-commerce platforms and manufacturer websites, are increasingly important for small-volume purchasers and quick replenishment. Together, these segmentation axes create a matrix of demand signals that manufacturers and suppliers must decode to align product development, marketing, and sales strategies effectively.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, regulatory priorities, and supply strategies

Regional dynamics materially influence both commercialization strategies and product development priorities. In the Americas, demand trends are shaped by a mature hospital infrastructure, expansive private hospital networks, and growing outpatient surgical capacity, which together create opportunities for both established PMMA-based products and emerging bioactive formulations that address infection control and osteointegration. The region's procurement sophistication encourages long-term supplier relationships and structured contracting mechanisms that reward evidence-backed performance and reliable supply chains.

In Europe, Middle East & Africa, regulatory harmonization and diverse healthcare models create a complex mosaic of adoption curves. Western European markets demand rigorous clinical data and often serve as launchpads for advanced bioactive materials, while markets in other parts of the region may emphasize cost-effectiveness and supply chain adaptability. Emerging markets within this region present growth potential driven by infrastructure investment and expanding access to surgical care, yet they require tailored distribution approaches and flexible pricing structures.

The Asia-Pacific region is characterized by a broad spectrum of market maturity, with high-volume centers in urban hubs adopting sophisticated materials and delivery systems, and peripheral settings prioritizing affordability and ease of use. Local manufacturing hubs and a thriving medtech innovation ecosystem in several countries are accelerating product localization and customization. Across all regions, supply chain resilience, regulatory alignment, and the ability to demonstrate clinical and economic value remain decisive factors for sustained adoption and market penetration.

Competitive landscape overview showing how incumbents, specialized innovators, and channel partners shape product differentiation and market access strategies

Competitive dynamics in the bone cement and surgical glue ecosystem are defined by a mixture of legacy manufacturers, specialty biomaterials firms, contract manufacturers, and innovative startups focused on next-generation bioactive chemistries. Established players benefit from entrenched relationships with large hospital systems, extensive commercial footprints, and experience with regulatory approvals across multiple jurisdictions. These incumbents often leverage scale to optimize manufacturing costs, invest in clinical evidence development, and offer bundled solutions that include instrumentation and training.

At the same time, midsized and emerging firms are differentiating through focused investments in niche technologies such as antibiotic-loaded cements with refined elution profiles, calcium phosphate systems designed for specific orthopedic niches, and high-precision delivery platforms that reduce intraoperative variability. Contract manufacturing organizations play an increasingly strategic role by enabling smaller innovators to scale production while managing quality systems and regulatory compliance.

Distribution partners, including national distributors and group purchasing organizations, act as gatekeepers to hospital formularies and ambulatory networks; their influence over purchasing decisions underscores the importance of channel strategies that balance direct sales relationships with broader distribution agreements. Partnerships and licensing arrangements are common as faster time-to-market and local regulatory alignment become priorities. Overall, competitive success hinges on a company's ability to demonstrate clinical differentiation, maintain supply continuity, and engage with stakeholders across procurement, clinical practice, and hospital leadership.

Actionable strategic priorities for manufacturers and suppliers to strengthen clinical differentiation, supply resilience, and commercial scalability in evolving care settings

Leaders in the bone cement and glue sector should adopt a multi-pronged strategy that addresses product excellence, supply chain resilience, and alignment with evolving clinical pathways. First, invest in clinical evidence programs that not only meet regulatory requirements but also generate real-world outcomes data demonstrating improvements in infection rates, implant stability, and patient recovery timelines. Such data supports differentiated value propositions during procurement negotiations and facilitates placement on hospital formularies and preferred vendor lists.

Second, diversify manufacturing and sourcing footprints to mitigate trade policy exposures and to ensure continuity of supply for critical hospital customers. This may include pursuing regional manufacturing partnerships, tolling agreements, or selective near-shoring to reduce lead times and tariff impacts. In tandem, optimize packaging and logistics to minimize transport costs and to meet the specific needs of ambulatory and outpatient settings where space and instrumentation differ from traditional operating theaters.

Third, refine commercial models to balance direct sales with distributor partnerships and digital channels. Direct engagement with large institutional buyers remains important for complex offerings, while distributors and online platforms can extend reach into smaller clinics and dental practices. Additionally, prioritize training and education programs that simplify product handling and demonstrate procedural efficiencies; clinicians value hands-on support and evidence-backed protocols that reduce intraoperative uncertainty.

Finally, pursue targeted R&D focused on user-centric product features such as adjustable setting times, improved radiopacity, and compatible delivery tools. Complement product development with strategic collaborations that accelerate clinical validation and regulatory approvals. Taken together, these actions will strengthen market positioning and create durable competitive advantage as clinical and procurement landscapes continue to evolve.

Robust mixed-methods research approach combining clinician interviews, supplier documentation analysis, and multi-source data triangulation to ensure actionable rigor

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure comprehensive, evidence-based insights. Primary research consisted of structured interviews with clinicians across orthopedics, craniofacial surgery, and dentistry, procurement leaders from hospitals and ambulatory surgical centers, product managers from biomaterials companies, and distribution executives. These conversations provided direct perspectives on clinical performance expectations, procurement decision drivers, and operational constraints that shape product selection.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available clinical study summaries to validate material properties, performance claims, and safety profiles. In addition, supplier documentation, product IFUs, and clinical technique guides were analyzed to assess handling characteristics and usage protocols. Data triangulation combined insights from primary interviews with secondary sources to identify convergent themes and to reconcile conflicting viewpoints.

Analytical techniques included thematic coding of qualitative transcripts, comparative feature mapping across product types and technologies, and scenario analysis to evaluate the impact of supply chain disruptions and policy shifts. Quality assurance steps encompassed cross-validation with multiple interviewees, peer review of draft findings by subject matter experts, and adherence to transparent documentation standards for data sources and methodological assumptions. This robust methodology ensures the findings offer both practical relevance and analytical rigor for stakeholders seeking to inform strategy and operational planning.

Strategic closing perspective highlighting the convergence of clinical performance, procurement priorities, and supply resilience that will determine future market leaders

In closing, the bone cement and surgical adhesive market is transitioning toward solutions that blend reliable mechanical performance with biological activity and practical handling for diverse procedural settings. This evolution is driven by clinical demand for improved outcomes, by procurement pressures that emphasize value and supply resilience, and by regulatory expectations that prioritize patient safety and evidence-based practice. Stakeholders that align product development with clinical workflows and that invest in scalable, regionally resilient supply models will be best positioned to capture emerging opportunities.

As the sector advances, success will increasingly depend on the ability to translate material science into executable clinical advantages-reducing infection risk, enhancing fixation, and improving patient recovery-while simultaneously navigating the complexities of distribution and procurement. Collaborative approaches that engage clinicians early in design, partner with regional manufacturers or contract manufacturers to secure supply, and employ data-driven value propositions will differentiate suppliers in a competitive landscape. Overall, the outlook favors those who can combine demonstrable clinical value with operational excellence and strategic agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in antibiotic-loaded PMMA bone cement formulations for targeted infection prevention in joint replacements
  • 5.2. Development of fully resorbable calcium phosphate-based bone glue enabling complete bone regeneration over time
  • 5.3. Integration of stem cell carriers into bioactive bone adhesive matrices to enhance localized tissue healing post surgery
  • 5.4. Adoption of dual-curing dental adhesives combining light activation and chemical setting for improved bonding durability
  • 5.5. Expansion of veterinary-grade bone cement applications in fracture repair surgeries for companion animals
  • 5.6. Use of 3D printing to create patient-specific bone cement molds for complex implant geometries in orthopedic procedures
  • 5.7. Collaboration between polymer chemists and orthopedic surgeons to develop thermosensitive injectable bone adhesives

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Cement & Glue Market, by Product Type

  • 8.1. Acrylic Bone Cement
    • 8.1.1. Antibiotic Loaded
    • 8.1.2. Non Antibiotic Loaded
  • 8.2. Calcium Phosphate Cement
    • 8.2.1. Injectable
    • 8.2.2. Moldable

9. Bone Cement & Glue Market, by Application

  • 9.1. Craniomaxillofacial
    • 9.1.1. Reconstructive Surgery
    • 9.1.2. Trauma Repair
  • 9.2. Dental
    • 9.2.1. Implantology
    • 9.2.2. Restorative
  • 9.3. Orthopedic
    • 9.3.1. Fracture Fixation
    • 9.3.2. Joint Replacement
    • 9.3.3. Spinal Surgery

10. Bone Cement & Glue Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Multi Specialty
    • 10.1.2. Orthopedic Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Clinics
    • 10.3.1. Dental Clinics
    • 10.3.2. Outpatient Rehab

11. Bone Cement & Glue Market, by Technology

  • 11.1. Bioactive
    • 11.1.1. Calcium Phosphate
    • 11.1.2. Calcium Silicate
  • 11.2. PMMA Based
    • 11.2.1. High Viscosity
    • 11.2.2. Low Viscosity

12. Bone Cement & Glue Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. OEM Relationships
    • 12.1.2. Tender Contracts
  • 12.2. Distributors
    • 12.2.1. Group Purchasing Organizations
    • 12.2.2. Independent Distributors
  • 12.3. Online Channels
    • 12.3.1. E Commerce Platforms
    • 12.3.2. Manufacturer Website

13. Bone Cement & Glue Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bone Cement & Glue Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bone Cement & Glue Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zimmer Biomet Holdings, Inc.
    • 16.3.2. Stryker Corporation
    • 16.3.3. DePuy Synthes, Inc.
    • 16.3.4. Heraeus Medical GmbH
    • 16.3.5. Smith & Nephew plc
    • 16.3.6. B. Braun Melsungen AG
    • 16.3.7. Medtronic plc
    • 16.3.8. TEI Biosciences, Inc.
    • 16.3.9. DJO Global, Inc.
    • 16.3.10. Paragon 28, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BONE CEMENT & GLUE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BONE CEMENT & GLUE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BONE CEMENT & GLUE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. N